World News: 13:00 GMT Thursday 9th May 2019. [Merus N.V. via Globe Newswire via SPi World News]
UTRECHT Netherlands May 09 2019 GLOBE NEWSWIRE -- Merus NVMRUS a clinical-stage immuno-oncology company developing Biclonicsreg innovative full-length human bispecific antibody therapeutics today that the first pat ient ha...
Globe Newswire: 13:00 GMT Thursday 9th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.